SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM

Clinical trial NCT05405166 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05405166
Sponsor: Sanofi
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Plasma Cell Myeloma Recurrent

Start date: 2022-06-23
Primary completion: 2024-11-06
Enrollment: 531

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.